Connecticut Hosts Psilocybin Mushroom Decriminalization Event Forum
On January 10, 2024, the Connecticut for Accessible Psychedelic Medicine (CAPM) held an online and in person forum with lawmakers and experts in Hartford, Connecticut.
The organization, Connecticut for Accessible Psychedelic Medicine (CAPM) hosted an in person and online public forum in regard to psilocybin mushroom decriminalization (1). The event took place between 10am to 12pm EST. From 12pm to 2pm EST, there will be a public comment period offered and takes place in Hartford, the state capitol of Connecticut (1). It can also be viewed on the Connecticut Network where it will be live streamed as well (1).
As mentioned in Psychedelic Week, the invited speakers in the morning session of the event included (1):
- Sarah Gersten, Executive Director of the Last Prisoner Project
- Larry Norris, PhD, Co-founder and National Organizing Director, Decriminalize Nature
- Ismail Ali, JD, Policy Director for the Multidisciplinary Association for Psychedelic studies (MAPS)
- Courtney Barnes, Feldman Legal Associates
- Mason Marks, MD, JD, Visiting Professor of Law, Harvard Law School; Senior Fellow & Project Lead, Project on Psychedelics Law & Regulation (POPLAR)
- Peter Grinspoon, MD, Harvard Medical Doctor
- Erin Doolittle, LMFT Marriage and family therapist
- Kevin Matthews, Denver Psilocybin Mushroom Policy Review Panel; Helix Consulting
- Jared Moffat, New Approach PAC
- Victor Constanza, Samuel Evans, LMSW, and Melissa Keilty, LMSW, Connecticut for Accessible Psychedelic Medicine (CAPM)
In 2023, a bill to decriminalize psilocybin partially in small amounts, passed the Connecticut House by a 86-64 vote (1). Unfortunately, the bill expired before gaining the chance to receive a final vote from the Senate. Representative Steve Stafstrom has plans to reintroduce the bill some time in 2024 (1). If the bill had passed legislation, it would have imposed a $150 fine but end a criminal penalty for having the possession of under a half an ounce of mushrooms. Some concerns have risen to the surface over law enforcement potentially seeking a boost in policing. These concerns have been raised by the New England Veterans for Plant Medicine and Bay Staters for Natural Medicine (1). Hopefully in 2024, the psilocybin decriminalization bill will be passed in the Connecticut Senate and be established into law.
Reference
- Marks, M. CT Lawmakers & Psilocybin Activists to Host Mushroom Decriminalization Forum https://www.psychedelicweek.com/p/connecticut-psilocybin-mushroom-law-policy-forum (accessed Jan 10, 2024).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
